1
Clinical Trials associated with AML Cell Vaccine(Kings College London)A Phase I Study of B7.1 (CD80)/IL-2 Immune Gene Therapy for High Risk MDS RAEB-2 and Acute Myeloid Leukaemia Patients Unsuitable for Allogeneic Haematological Stem Cell Transplant
The study will be an open label, single arm, phase I study intended to identify the safety and tolerability of "AML Cell Vaccine" given to eligible MDS RAEB-2 and AML patients who have achieved a best response of complete remission or partial remission following their first or second course of standard induction chemotherapy.
100 Clinical Results associated with AML Cell Vaccine(Kings College London)
100 Translational Medicine associated with AML Cell Vaccine(Kings College London)
100 Patents (Medical) associated with AML Cell Vaccine(Kings College London)
100 Deals associated with AML Cell Vaccine(Kings College London)